Item 2.02 Results of Operations and Financial Condition.

On January 9, 2023, STAAR Surgical Company (the "Company") published a press release reporting selected preliminary financial results for the quarter and fiscal year ended December 30, 2022, a copy of which is furnished as Exhibit 99.1 to this Report and is incorporated herein by this reference. The financial information is unaudited and subject to adjustment in the final audited financial statements to be filed with the Company's Annual Report on Form 10-K. The Company expects to report its complete 2022 financial results on its fourth-quarter and full-year earnings call, which it will hold later in the first quarter of 2023.

The information furnished herewith pursuant to Item 2.02 of this Current Report, including Exhibit 99.1 shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.

Item 9.01 Financial Statements and Exhibits



Exhibit No.    Description

99.1             Press release of the Company dated January 9, 2023  .

104            Cover Page Interactive Data File (embedded within the Inline XBRL
               document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses